Cargando…

P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Detalles Bibliográficos
Autores principales:	Schmidt, C, Jaoko, W, Kaleebu, P, Karita, E, Lehrman, Allen, S, Dally, L, Smith, C, Fast, PE
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767695/ http://dx.doi.org/10.1186/1742-4690-6-S3-P201

Ejemplares similares

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
por: Mpendo, J, et al.
Publicado: (2012)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
por: Bayingana, R, et al.
Publicado: (2012)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
por: Karita, E, et al.
Publicado: (2009)

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda
por: Mukamuyango, J, et al.
Publicado: (2012)

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India
por: Kochhar, S, et al.
Publicado: (2009)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
por: Ngongo, BP, et al.
Publicado: (2012)

P20-14. Co- and superinfection of partners in a cohort of couples previously infected by genotypically different viruses in Kigali
por: Manigart, O, et al.
Publicado: (2009)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
por: Allen, MA, et al.
Publicado: (2009)

Efficacy of non-specific hemostatic agents for reversal of prophylactic apixaban levels
por: Schmidt, K, et al.
Publicado: (2015)

HIV disease progression compared by linkage status in Rwanda and Zambia
por: Kilembe, W, et al.
Publicado: (2012)

P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand
por: Pitisuttithum, P, et al.
Publicado: (2009)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
por: Mutua, G, et al.
Publicado: (2012)

P19-27. Willingness of adolescents in Soweto, South Africa to participate in future HIV prevention trials
por: Makongoza, N, et al.
Publicado: (2009)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
por: Mpendo, J, et al.
Publicado: (2009)

Introduction of electronic data capture method using participant-completed online web-based follow up questionnaire in mail-based study achieves expected benefits and positive participant feedback
por: Barton, Jill, et al.
Publicado: (2015)

Retention of skills during emergency airway management training: a 12-month follow-up
por: Fischer, H, et al.
Publicado: (2010)

P03-14 Barriers to sports participation among adolescent girls from deprived neighbourhoods
por: Ljungmann, Cecilie Karen, et al.
Publicado: (2022)

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study
por: Lindegger, G, et al.
Publicado: (2012)

P091: Timely administering prophylactic antibiotics
por: Yau, Y, et al.
Publicado: (2013)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Increased epithelial thickness and reduced HIV receptor expression in the ectocervical mucosa is associated with relative HIV resistance
por: Broliden, K, et al.
Publicado: (2012)

Prophylactic use of laxative for constipation in critically ill patients
por: Masri, Y, et al.
Publicado: (2010)

Prophylactic treatment with bicillin-5 and timalin of convalescence of erysipelas
por: Iarovoi, Liviu, et al.
Publicado: (2013)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

Long term follow up of children with rheumatological conditions who participated in a two week rehabilitation programme
por: Mato, H, et al.
Publicado: (2008)

Prophylactic treatments of migraine and GPs in the north of France: evaluation of practices
por: Christian, CL
Publicado: (2013)

Application and efficacy of levetiracetam in prophylactic treatment of migraine without aura
por: Maykova, TN
Publicado: (2013)

P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009
por: Tounkara, K, et al.
Publicado: (2009)

Effects of 14 days of prophylactic resveratrol supplementation in trained endurance runners upon the inflammatory markers TNF-a, IL1β, and IL-6 following a single bout of eccentric exercise
por: Dufour, Fanny, et al.
Publicado: (2011)

A bacterial immune-prophylactic approach against asthma for infants and children
por: Loeffler, Daniela IM, et al.
Publicado: (2010)

Screening breast MRI in high-risk women undergoing prophylactic mastectomy
por: McWilliams, SE
Publicado: (2012)

Prophylactic modalities against venous thromboembolism in complicated surgery for cancer patients
por: Salem, W, et al.
Publicado: (2008)

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA
por: Bakari, M, et al.
Publicado: (2009)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

Trauma patients with prophylactic IVC filter and chemical prophylaxis: a descriptive study
por: Perreault, MM, et al.
Publicado: (2010)

Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
por: Dewulf, B, et al.
Publicado: (2013)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Minimal persistent inflammation in Japanese cedar pollinosis and a prophylactic effect of intranasal corticosteroids
por: Noyama, Yasuyuki, et al.
Publicado: (2013)

PA01.14. Study of Herbal combination in HIV infection
por: Tumbare, Sanjay, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0m2v8b76ok60dh28sbhnabs7kp